Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tests Of Nanosilver-Based Consumer Products Needed To Define Risks – PEN

This article was originally published in The Tan Sheet

Executive Summary

Widespread use in toothpaste and other consumer products of nanosilver - one of the most toxic metals to aquatic organisms - highlights the need for research to better manage the ingredient's environmental and human health risks, according to a new report from the Project on Emerging Nanotechnologies

You may also be interested in...



EPA Would Regulate Nano Materials Under Research Project’s Proposal

A report commissioned by the Project on Emerging Nanotechnologies proposes a five-year strategy lawmakers and the Environmental Protection Agency, among others, can follow to create an "intelligent" approach to nanotechnology oversight

Washington State Ecology Mulls ‘Safer’ Definition While Exploring Phthalate Alternatives In Fragrances

Marissa Smith, senior regulatory toxicologist in the Washington Department of Ecology’s Hazardous Waste and Toxics Reduction program, discusses what’s next for the state’s inaugural Safer Products go-round. “How we define ‘safer’ is really going to be the lynchpin of this whole process,” she says.

CBD Sheet Mask Brand Fails To Sway NAD: We Only Claimed It ‘May’ Have Benefits

The National Advertising Division has notified the US Federal Trade Commission of claims seen at Bloomingdales.com for one of Mask, LLC’s CBD-infused sheet masks, including the product’s name, which implies unsupported acne treatment benefits, according to the NAD.

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel